Accessibility settings

This paper is in the following e-collection/theme issue:

Health Services Research in Oncology (73) Cost-Effectiveness and Economics (387) Equity and Digital Divide (440) Vulnerable Populations in Health Research (275)

Published on in Vol 12 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/68101, first published .
Financial Toxicity of Hematologic Malignancy Therapies, Including Cellular Therapy and Its Impact on Access to Care: Prospective Pilot Study

Financial Toxicity of Hematologic Malignancy Therapies, Including Cellular Therapy and Its Impact on Access to Care: Prospective Pilot Study

Financial Toxicity of Hematologic Malignancy Therapies, Including Cellular Therapy and Its Impact on Access to Care: Prospective Pilot Study

Authors of this article:

Lemchukwu Amaeshi1, 2 Author Orcid Image ;   Lauren Laufer1, 3 Author Orcid Image ;   Kateryna Fedorov4, 5 Author Orcid Image ;   Alex Sisto1, 6 Author Orcid Image ;   David Levitz4 Author Orcid Image ;   Rosmi Mathew1 Author Orcid Image ;   Karen Wright1 ;   Dennis Cooper4 Author Orcid Image ;   Mendel Goldfinger4 Author Orcid Image ;   Ioannis Mantzaris4 Author Orcid Image ;   R Alejandro Sica4 Author Orcid Image ;   Kira Gritsman4 Author Orcid Image ;   Marina Konopleva4, 7 Author Orcid Image ;   Ridhi Gupta4 Author Orcid Image ;   Noah Kornblum4 Author Orcid Image ;   Chenxin Zhang2 Author Orcid Image ;   Mimi Kim2 Author Orcid Image ;   Amit Verma4 Author Orcid Image ;   Bruce Rapkin1, 2 Author Orcid Image ;   Aditi Shastri4 Author Orcid Image ;   Nishi Shah4 Author Orcid Image
Article Authors Cited by (1) Tweetations Metrics

Journals

  1. Halpin S. Financial toxicity as logistical and relational burden across the lifespan during autologous transplant preparation. Frontiers in Cancer Control and Society 2026;4 View